Clinical Practice Guideline
Clinical Practice Guideline for the Management of Infantile Hemangioma (Published January 2019)
Healthy Children: About Strawberry Baby Birthmarks – Covers general characteristics, similar marks, as when to contact a provider, as well as potential treatment options.
Healthy Children: Baby Birthmarks and Rashes – Overview of different types of birthmarks and rashes (English).
Healthy Children: Baby Birthmarks and Rashes – Overview of different types of birthmarks and rashes (Spanish).
Healthy Children: Prevent Potential Problems from Common Type of Baby Birthmarks – Brief overview of the AAP’s guideline on infantile hemangioma focusing on early identification and discouraging the traditional “wait and see” approach (English).
Healthy Children: Prevent Potential Problems from Common Type of Baby Birthmarks – Brief overview of the AAP’s guideline on infantile hemangioma focusing on early identification and discouraging the traditional “wait and see” approach (Spanish).
Information for Families: What are Hemangiomas? – Information for parents on what to expect, possible complications, and potential treatments.
Information for Families: Propranolol for Hemangiomas – Information for parents on when to treat and what treating with Propranolol entails.
Medication Information: Propanolol Treatment for Infantile Hemangiomas – Additional information/instructions for parents to consider when giving Propranolol and what side effects may occur during treatment.
Infantile Hemangioma (IH) Types: Classification of IHs – Photographic examples of the varying classifications of IHs.
Risk Level of Infantile Hemangiomas of Varying Types – The table is designed to aid in the assessment of risk posed by the IH during evaluation.
Infantile Hemangioma Example Photos – Photographic examples of IHs that meet one of the following: require immediate consultation or referral; require consultation or referral; may require consultation or referral; OR that usually do not require referral.
Pediatric Care Online Webinar: Infantile Hemangioma – Increase your knowledge on how to risk-stratify infantile hemangiomas, understand the natural history of hemangiomas and how this affects referral and management, and increase your awareness of treatment options for infantile hemangiomas requiring treatment.
Health Initiatives: Diagnosis and Management of Infantile Hemangioma (IH) – A collection of provider-focused resources that are designed to aid in the identification, treatment, and/or management of IHs.
Infantile Hemangioma (IH) Quality Improvement (QI) Metrics – Measurable outcomes that are typically based on key action statements. This resource consists of inclusion/exclusion criteria, overall aim/goal, and descriptions of the numerators/denominators needed to calculate the metric.
Infantile Hemangioma Key Driver Diagram – This resource serves as a map or guide to quality improvement. Aims are usually identified with key drivers serving as the “what” you need to do and the secondary drivers or implementation tools/resources serving as the “how” you will achieve the desired change.
Action Needed for an Infant ≤ 3 Months of Age Being Seen with an Infantile Hemangioma (IH) – A flow diagram designed to determine the action recommended based on associated risk of the hemangioma.
Infantile Hemangioma (IH) Initial Clinical Assessment for Patients ≤ 3 Months of Age – Prospective tool intended to facilitate a standardized initial assessment of individual patients with suspected IH consistent with the AAP guideline.
Infantile Hemangioma Quality Improvement Data Collection Tool – Intended to support data collection for the IH QI Metrics.